Skip to Main Content

Paper Details

Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.
JAMA Dermatol
4
2023
CDKN2A, CDKN2A splicing variant, CDKN2A-Related Melanoma-Astrocytoma Syndrome, Cutaneous neurofibromas, MAS, NF1, NF1 gene, NF1 genetic alterations, Neurofibromatosis Type 1, Patients, Tumor, astrocytoma, brain neoplasms, c.151-, cutaneous melanoma, glioblastoma, glioblastomas, gliosarcoma, head and neck squamous cell carcinoma, liposarcoma, malignant peripheral nerve sheath tumor, melanoma-astrocytoma syndrome, neural, neural cancers, neural tumors, neurofibromatosis type 1, nonneural, nonneural cancers, nonneural malignant neoplasms, patients, sarcomas, schwannomas, tumor, tumors, women
Author NameAffiliation
Jung KimNational Cancer Institute, National Institutes of Health
Jung KimNational Cancer Institute, National Institutes of Health
Yazmin OdiaMiami Cancer Institute
Brigitte C WidemannCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Jack F ShernCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Xiaohong R YangNational Cancer Institute, National Institutes of Health
Xiaohong R YangNational Cancer Institute, National Institutes of Health
David J CareyGeisinger Clinic
David J CareyGeisinger Clinic
Margaret A TuckerNational Cancer Institute, National Institutes of Health
Margaret A TuckerNational Cancer Institute, National Institutes of Health
Douglas R StewartNational Cancer Institute, National Institutes of Health
Douglas R StewartNational Cancer Institute, National Institutes of Health
  • 1 - 13

Datasets

Release 1.2